Stockreport

Clene Issues Stockholder Letter Highlighting Upcoming CNM-Au8® 2026 Catalysts

Clene Inc.  (CLNN) 
PDF Operating capital runway sufficient into the fourth quarter of 2026 In-person Type C FDA meeting scheduled by end of the first quarter of 2026 to discuss the latest CNM- [Read more]